Minwei Biotechnology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Minwei Biotechnology - overview
Established
2021
Location
Shanghai, -, China
Primary Industry
Biotechnology
About
Based in China, Minwei Biotechnology is a large molecule biopharmaceutical developer focusing on metabolic diseases and their complications, cardiovascular diseases and other fields. In September 2025, Minwei Biotechnology raised a series A+ funding from new investor Tencent Investment and other unspecified investors.
Current Investors
Tencent Investment
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Healthcare Specialists, Pharmaceuticals
Website
http://www.minweibiotech.cn
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.